Insider Transactions in Q3 2024 at Lexeo Therapeutics, Inc. (LXEO)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2024
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.98%
|
$50,000
$10.65 P/Share
|
|
Sep 10
2024
|
Richard Nolan Townsend Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.83%
|
$10,000
$2.33 P/Share
|
|
Aug 12
2024
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.98%
|
$55,000
$11.53 P/Share
|
|
Aug 12
2024
|
Richard Nolan Townsend Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.83%
|
$10,000
$2.33 P/Share
|
|
Jul 11
2024
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,031
-9.43%
|
$504,558
$18.06 P/Share
|
|
Jul 10
2024
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,969
-7.82%
|
$431,504
$16.65 P/Share
|
|
Jul 10
2024
|
Richard Nolan Townsend Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.77%
|
$10,000
$2.33 P/Share
|